154 related articles for article (PubMed ID: 30773559)
21. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
[TBL] [Abstract][Full Text] [Related]
22. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
Zheng H; Zhang Y; Zhan Y; Liu S; Lu J; Wen Q; Fan S
Oncol Rep; 2019 Dec; 42(6):2363-2370. PubMed ID: 31638235
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.
Zhang X; Li P; Rong M; He R; Hou X; Xie Y; Chen G
Tohoku J Exp Med; 2015 Mar; 235(3):161-9. PubMed ID: 25746592
[TBL] [Abstract][Full Text] [Related]
24. More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells.
Zhang SY; Hui LP; Li CY; Gao J; Cui ZS; Qiu XS
BMC Cancer; 2016 Feb; 16():171. PubMed ID: 26926340
[TBL] [Abstract][Full Text] [Related]
25. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of IGF1R expression in non-small-cell lung cancer.
Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
[TBL] [Abstract][Full Text] [Related]
27. GRK5 functions as an oncogenic factor in non-small-cell lung cancer.
Jiang LP; Fan SQ; Xiong QX; Zhou YC; Yang ZZ; Li GF; Huang YC; Wu MG; Shen QS; Liu K; Yang CP; Chen YB
Cell Death Dis; 2018 Feb; 9(3):295. PubMed ID: 29463786
[TBL] [Abstract][Full Text] [Related]
28. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
Ma H; Wang L; Zhang T; Shen H; Du J
Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
[TBL] [Abstract][Full Text] [Related]
29. Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma.
Liu ZY; Wu T; Li Q; Wang MC; Jing L; Ruan ZP; Yao Y; Nan KJ; Guo H
Medicine (Baltimore); 2016 May; 95(20):e3715. PubMed ID: 27196489
[TBL] [Abstract][Full Text] [Related]
30. [Expression of NUSAP1 and its relationship with prognosis in non-small cell lung cancer].
Yu Z; Li XM; Huai M; Cao SS; Han HY; Liu HT
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):522-526. PubMed ID: 31357839
[No Abstract] [Full Text] [Related]
31. [Overexpression of OLC1 in Lung Squamous Cell Carcinoma Tissues is Associated with Poor Prognosis of Patients].
Zhang K; Zhao G; Xiao T; Li P; Song J; Gao Y; Sun K
Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):346-351. PubMed ID: 28532543
[TBL] [Abstract][Full Text] [Related]
32. Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma.
Jiang A; Gao X; Zhang D; Zhang L; Lu H
Oncol Lett; 2013 Aug; 6(2):375-380. PubMed ID: 24137332
[TBL] [Abstract][Full Text] [Related]
33. [Up-regulation of DLK1 in non-small cell lung cancer and the relevant molecular mechanism].
Zhang SS; Tan JJ; Li L; Chen WT; Han NJ; Guo SP; Zheng S; Liu Y; Gao YN
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):510-4. PubMed ID: 27531264
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning.
Giraud P; Antoine M; Larrouy A; Milleron B; Callard P; De Rycke Y; Carette MF; Rosenwald JC; Cosset JM; Housset M; Touboul E
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1015-24. PubMed ID: 11072158
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.
Abel S; Hasan S; White R; Schumacher L; Finley G; Colonias A; Wegner RE
Lung Cancer; 2019 Feb; 128():127-133. PubMed ID: 30642444
[TBL] [Abstract][Full Text] [Related]
36. Beta1- and Beta2-Adrenoceptors Expression Patterns in Human Non-small Cell Lung Cancer: Relationship with Cancer Histology.
Coelho M; Imperatori A; Chiaravalli AM; Franzi F; Castiglioni M; Rasini E; Luini A; Legnaro M; Marino F; Ribeiro L; Cosentino M
J Neuroimmune Pharmacol; 2019 Dec; 14(4):697-708. PubMed ID: 31620969
[TBL] [Abstract][Full Text] [Related]
37. Expression and clinical significance of miR-139-5p in non-small cell lung cancer.
Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z
J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
39. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.
Shimizu H; Yamagishi S; Chiba H; Ghazizadeh M
Adv Clin Exp Med; 2016; 25(1):117-28. PubMed ID: 26935506
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
